tradingkey.logo

Sonoma Pharmaceuticals Inc

SNOA
3.030USD
-0.030-0.98%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
5.00MMarktkapitalisierung
VerlustKGV TTM

Sonoma Pharmaceuticals Inc

3.030
-0.030-0.98%

mehr Informationen über Sonoma Pharmaceuticals Inc Unternehmen

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Inc Informationen

BörsenkürzelSNOA
Name des UnternehmensSonoma Pharmaceuticals Inc
IPO-datumJan 26, 2007
CEOTrombly (Amy)
Anzahl der mitarbeiter168
WertpapierartOrdinary Share
GeschäftsjahresendeJan 26
Addresse5445 Conestoga Court, Suite 150
StadtBOULDER
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl80301
Telefon18007599305
Websitehttps://sonomapharma.com/
BörsenkürzelSNOA
IPO-datumJan 26, 2007
CEOTrombly (Amy)

Führungskräfte von Sonoma Pharmaceuticals Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-1.00%
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-1.00%
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Human Care
5.12M
91.29%
Animal Care
488.00K
8.71%
Nach RegionUSD
Name
Umsatz
Anteil
Europe
2.15M
38.38%
United States
1.45M
25.86%
Asia
1.06M
18.86%
Latin America
532.00K
9.49%
Rest of the world
415.00K
7.41%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Human Care
5.12M
91.29%
Animal Care
488.00K
8.71%

Aktionärsstatistik

Aktualisiert: Sat, Feb 7
Aktualisiert: Sat, Feb 7
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
1.11%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
McKinley Carter Wealth Services, Inc.
0.66%
Thornton (Bruce)
0.45%
Andere
95.74%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
1.11%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
McKinley Carter Wealth Services, Inc.
0.66%
Thornton (Bruce)
0.45%
Andere
95.74%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
2.86%
Individual Investor
1.24%
Investment Advisor/Hedge Fund
1.04%
Hedge Fund
0.09%
Research Firm
0.05%
Andere
94.72%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
39
57.27K
3.37%
-75.31K
2025Q3
34
106.22K
6.24%
+25.12K
2025Q2
39
61.63K
4.65%
-24.83K
2025Q1
40
54.41K
3.31%
-8.75K
2024Q4
40
41.45K
2.57%
-24.32K
2024Q3
41
49.08K
3.40%
+9.77K
2024Q2
40
43.04K
3.61%
+17.90K
2024Q1
38
20.55K
2.85%
-9.28K
2023Q4
36
27.53K
4.02%
+7.17K
2023Q3
35
18.63K
7.25%
-6.00K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
20.87K
1.23%
+2.09K
+11.10%
Sep 30, 2025
Geode Capital Management, L.L.C.
17.62K
1.04%
--
--
Sep 30, 2025
DRW Securities, LLC
17.07K
1%
+17.07K
--
Sep 30, 2025
Thornton (Bruce)
7.72K
0.45%
-1.00
-0.01%
Jul 08, 2025
Trombly (Amy Moss)
7.68K
0.45%
--
--
Jul 08, 2025
Dvonch (Jerome J)
4.23K
0.25%
-1.00
-0.02%
Jul 08, 2025
Tower Research Capital LLC
1.54K
0.09%
+536.00
+53.60%
Sep 30, 2025
Dal (Poggetto John)
910.00
0.05%
+910.00
--
Jun 20, 2024
Global Retirement Partners, LLC
438.00
0.03%
+438.00
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Datum
Ex-Dividendentag
Art
Verhältnis
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
KeyAI